1. |
Ishak KG. Mesenchymal tumors of the liver//Okuda K, Peters RL. Hepatocellular Carcinoma. New York: John Wiley, 1976.
|
2. |
Chen W, Liu Y, Zhuang Y, et al. Hepatic perivascular epithelioid cell neoplasm: A clinical and pathological experience in diagnosis and treatment. Mol Clin Oncol, 2017, 6(4): 487-493.
|
3. |
Hornick JL, Fletcher CD. PEComa: what do we know so far? Histopathology, 2006, 48(1): 75-82.
|
4. |
Im S, Yoo C, Jung JH, et al. Primary perivascular epithelioid cell tumor in the rectum: a case report and review of the literature. Pathol Res Pract, 2013, 209(4): 244-248.
|
5. |
Yu D, Tang S. Hepatic perivascular epithelioid cell tumor: a case report and review of the literature. Intern Med, 2013, 52(12): 1333-1336.
|
6. |
Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma: diagnostic findings and management. Int J Hepatol, 2012, 2012: 410781.
|
7. |
Lu HC, Chau GY, Su CW. Clinical challenges and images in GI. Diagnosis: Hepatic angiomyolipoma mimicking hepatocellular carcinoma. Gastroenterology, 2009, 136(4): 1169, 1464.
|
8. |
刘露, 鲁亚, 刘曦娇, 等. 肝上皮样血管内皮细胞瘤的影像学表现. 中国普外基础与临床杂志, 2018, 25(2): 229-234.
|
9. |
Liu J, Zhang CW, Hong DF, et al. Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized. World J Gastroenterol, 2016, 22(20): 4908-4917.
|
10. |
Flemming P, Lehmann U, Becker T, et al. Common and epithelioid variants of hepatic angiomyolipoma exhibit clonal growth and share a distinctive immunophenotype. Hepatology, 2000, 32(2): 213-217.
|
11. |
Yang X, Li A, Wu M. Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol, 2013, 30(1): 416.
|
12. |
路涛, 周翔平, 姜兴莲, 等. 肝血管平滑肌脂肪瘤的影像学表现及其诊断(附3例报道). 中国普外基础与临床杂志, 2010, 17(8): 860-864.
|
13. |
Xu AM, Zhang SH, Zheng JM, et al. Pathological and molecular analysis of sporadic hepatic angiomyolipoma. Hum Pathol, 2006, 37(6): 735-741.
|
14. |
Argani P, Aulmann S, Illei PB, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol, 2010, 34(10): 1395-1406.
|
15. |
Jimbo N, Nishigami T, Noguchi M, et al. Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations. Hum Pathol, 2017, 61: 41-48.
|
16. |
Nguyen TT, Gorman B, Shields D, et al. Malignant hepatic angiomyolipoma: report of a case and review of literature. Am J Surg Pathol, 2008, 32(5): 793-798.
|
17. |
Klompenhouwer AJ, Verver D, Janki S, et al. Management of hepatic angiomyolipoma: A systematic review. Liver Int, 2017, 37(9): 1272-1280.
|
18. |
Brimo F, Robinson B, Guo C, et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol, 2010, 34(5): 715-722.
|
19. |
Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol, 2005, 29(12): 1558-1575.
|
20. |
Huang SC, Chuang HC, Chen TD, et al. Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2. Histopathology, 2015, 66(5): 695-705.
|
21. |
Agaram NP, Sung YS, Zhang L, et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol, 2015, 39(6): 813-825.
|
22. |
Italiano A, Delcambre C, Hostein I, et al. Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa. Ann Oncol, 2010, 21(5): 1135-1137.
|